Pfizer reported that its Covid-19 vaccine had a 95 percent efficacy rating. That topped the 94.5 percent reported by Moderna last week. The race is on to see who can hit 96% first!
While that news is certainly great overall, it will still take time to mass produce and distribute the drug. Healthcare workers on the front line may see the first batches in the next month. In any event, it’s clear that the market isn’t quite ready to head materially higher until the vaccine can be distributed. That’ something we’ve warned about before — but that warning also carries an opportunity for trading both up and down.
Now here’s the rest of the news:
November 19, 2019
Not only is this the season for shopping, buying various articles, there are two sides to everything…
DarrenDaily’s message today … “The Framework for Selling Success”
Are you enjoying the season? [Please don’t over-do-it.] 😉